It is important to know the length of the tumor for planning radiotherapy ports or surgery. After adequate staging, if the patient is a surgical candidate, the next step is to determine the resectability of the tumor. Here, we should focus on two groups of patients. Any patient who should have surgery or multimodal treatment must have a careful risk analysis. Experienced surgical teams have an excellent record of lowering surgical mortality.
Morbidity is moderate for patients receiving combined modality treatment.
For the patient in question, an attempt for cure with definitive chemoradiotherapy would be appropriate. During therapy, it is important to emphasize the value of nutritional support and good mouth care, to prevent complications with increasing morbidity during therapy. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. Combined modality therapy in the treatment of esophageal cancer. Inc. All rights reserved.